A phase II trial of safety and efficacy of ADRCs delivered via the intracoronary route in the treatment of patients with ST-elevation acute myocardial infarction.

Funding source: The ADVANCE Clinical Trial Cytori Therapeutics, Inc. San Diego, USA
Project Researcher

The aim of the trial was further examination and assessment of the efficacy of ADRCs (adipose-derived regenerative cells), generated by means of Celution ® System, in the treatment of patients with ST-elevation acute myocardial infarction. The examined medical product – stem cells and regenerative cells, were administered via the intracoronary route, delivering blood to the injured parts of the heart.